Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Journal of Immunological Methods
|
January 29, 2009
'Fit-for-purpose' validation of SearchLight multiplex ELISAs of angiogenesis for clinical trial use
A C Backen, J Cummings, C Mitchell, et al.
NMR in Biomedicine
|
March 1, 2002
Breath-hold perfusion and permeability mapping of hepatic malignancies using magnetic resonance imaging and a first-pass leakage profile model
A Jackson, H Haroon, X P Zhu, et al.
British Journal of Cancer
|
February 14, 1998
Bryostatin 1-tamoxifen combinations show synergistic effects on the inhibition of growth of P388 cells in vitro
A T McGown, G Jayson, G R Pettit, et al.
Cancer Immunology, Immunotherapy : CII
|
October 1, 1994
Immunomodulation in patients receiving intravenous Bryostatin 1 in a phase I clinical study: comparison with effects of Bryostatin 1 on lymphocyte function in vitro
C Scheid, J Prendiville, G Jayson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 23, 2002
The EORTC and drug development. European Organisation for Research and Treatment of Cancer
D Lacombe, P Fumoleau, H Zwierzina, et al.
Biochemical and Biophysical Research Communications
|
July 16, 2008
Quantitative multiplexed quantum dot immunohistochemistry
E Sweeney, T H Ward, N Gray, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications
|
July 8, 1998
High-performance liquid chromatographic assay for the novel antitumor drug, bryostatin-1, incorporating a serum extraction technique
P Khan, A T McGown, M J Dawson, et al.
British Journal of Cancer
|
June 29, 2006
Method validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linked inhibitor of apoptosis protein XIAP
J Cummings, M Ranson, E Lacasse, et al.
British Journal of Cancer
|
February 7, 2013
Targeted anti-vascular therapies for ovarian cancer: current evidence
M Hall, C Gourley, I McNeish, et al.
European Journal of Cancer Care
|
January 8, 2014
Accessing cancer services in North West England: the Chinese population
A M Conway, A R Clamp, J Hasan, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Journal of Immunological Methods
|
January 29, 2009
'Fit-for-purpose' validation of SearchLight multiplex ELISAs of angiogenesis for clinical trial use
A C Backen, J Cummings, C Mitchell, et al.
NMR in Biomedicine
|
March 1, 2002
Breath-hold perfusion and permeability mapping of hepatic malignancies using magnetic resonance imaging and a first-pass leakage profile model
A Jackson, H Haroon, X P Zhu, et al.
British Journal of Cancer
|
February 14, 1998
Bryostatin 1-tamoxifen combinations show synergistic effects on the inhibition of growth of P388 cells in vitro
A T McGown, G Jayson, G R Pettit, et al.
Cancer Immunology, Immunotherapy : CII
|
October 1, 1994
Immunomodulation in patients receiving intravenous Bryostatin 1 in a phase I clinical study: comparison with effects of Bryostatin 1 on lymphocyte function in vitro
C Scheid, J Prendiville, G Jayson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 23, 2002
The EORTC and drug development. European Organisation for Research and Treatment of Cancer
D Lacombe, P Fumoleau, H Zwierzina, et al.
Biochemical and Biophysical Research Communications
|
July 16, 2008
Quantitative multiplexed quantum dot immunohistochemistry
E Sweeney, T H Ward, N Gray, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications
|
July 8, 1998
High-performance liquid chromatographic assay for the novel antitumor drug, bryostatin-1, incorporating a serum extraction technique
P Khan, A T McGown, M J Dawson, et al.
British Journal of Cancer
|
June 29, 2006
Method validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linked inhibitor of apoptosis protein XIAP
J Cummings, M Ranson, E Lacasse, et al.
British Journal of Cancer
|
February 7, 2013
Targeted anti-vascular therapies for ovarian cancer: current evidence
M Hall, C Gourley, I McNeish, et al.
European Journal of Cancer Care
|
January 8, 2014
Accessing cancer services in North West England: the Chinese population
A M Conway, A R Clamp, J Hasan, et al.
Page
of 3